Consistent with this idea, Maher et al. quantified 123 circulating proteins in patients with IPF and identified a new IPF-associated protein, cancer antigen-125 protein, rising levels of which were associated with the risk of disease progression and mortality [29]. The gene discussed is MUC16; the disease is idiopathic pulmonary fibrosis.